1. APOHEALTH paracetamol supplied without child-resistant packaging

   News item 02 December 2023 Pages: 1 - 1

2. FDA warns against use of Neptune's Fix due to severe AEs

   News item 02 December 2023 Pages: 2 - 2

3. Influenza-virus vaccination during pregnancy: no serious, no unexpected side effects

   News item 02 December 2023 Pages: 3 - 3

4. Paxlovid: risk of drug interactions

   News item 02 December 2023 Pages: 4 - 4

5. Recall of OTC pain and fever reliever products for children due to acetaminophen instability

   Media release 02 December 2023 Pages: 5 - 5

6. AEs of nusinersen, risdiplam and onasemnogene abeparvovec

   Clinical study 02 December 2023 Pages: 6 - 6

7. Brexpiprazole: safety assessment reveals new potential risks

   Clinical study 02 December 2023 Pages: 7 - 7

8. Clozapine-associated adverse drugs reactions

   Clinical study 02 December 2023 Pages: 8 - 8

9. Glutathione peroxidase inhibitors associated with COPD

   Clinical study 02 December 2023 Pages: 9 - 9

10. Haematological toxicity of PARP inhibitors in metastatic prostate cancer

    Clinical study 02 December 2023 Pages: 10 - 10

11. Immune checkpoint inhibitors may increase risk of AKI

    Clinical study 02 December 2023 Pages: 11 - 11

12. Levetiracetam interaction with DOACs may cause ischaemic stroke

    Clinical study 02 December 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 02 December 2023 Pages: 13 - 13

14. Abatacept

    Case report 02 December 2023 Pages: 14 - 14

15. Abiraterone

    Case report 02 December 2023 Pages: 15 - 15

16. Abiraterone

    Case report 02 December 2023 Pages: 16 - 16

17. Abiraterone/Hydrocortisone

    Case report 02 December 2023 Pages: 17 - 17

18. Acetazolamide

    Case report 02 December 2023 Pages: 18 - 18

19. Aciclovir/Naloxone

    Case report 02 December 2023 Pages: 19 - 19

20. Aciclovir/prednisone

    Case report 02 December 2023 Pages: 20 - 20

21. Ad26.cov2-s/tozinameran

    Case report 02 December 2023 Pages: 21 - 22

22. Ad26.cov2-s/tozinameran

    Case report 02 December 2023 Pages: 22 - 22

23. Adalimumab

    Case report 02 December 2023 Pages: 23 - 23

24. Adalimumab

    Case report 02 December 2023 Pages: 24 - 24

25. Adalimumab/etanercept

    Case report 02 December 2023 Pages: 25 - 25

26. Afatinib

    Case report 02 December 2023 Pages: 26 - 26

27. Aflibercept/faricimab

    Case report 02 December 2023 Pages: 27 - 27

28. Albendazole

    Case report 02 December 2023 Pages: 28 - 28

29. Alectinib

    Case report 02 December 2023 Pages: 29 - 29

30. Alectinib/doxorubicin/ifosfamide

    Case report 02 December 2023 Pages: 30 - 30

31. Alemtuzumab

    Case report 02 December 2023 Pages: 31 - 31

32. Alendronic-acid/Denosumab

    Case report 02 December 2023 Pages: 32 - 32

33. Allopurinol

    Case report 02 December 2023 Pages: 33 - 33

34. Alpelisib/antidiabetics

    Case report 02 December 2023 Pages: 34 - 34

35. Alpelisib/toripalimab

    Case report 02 December 2023 Pages: 35 - 35

36. Ambroxol

    Case report 02 December 2023 Pages: 36 - 36

37. Amiodarone

    Case report 02 December 2023 Pages: 37 - 37

38. Amiodarone

    Case report 02 December 2023 Pages: 38 - 38

39. Amiodarone

    Case report 02 December 2023 Pages: 39 - 39

40. Amiodarone

    Case report 02 December 2023 Pages: 40 - 40

41. Amiodarone

    Case report 02 December 2023 Pages: 41 - 41

42. Amiodarone

    Case report 02 December 2023 Pages: 42 - 42

43. Amiodarone

    Case report 02 December 2023 Pages: 43 - 43

44. Amiodarone/Beta-adrenergic-receptor-antagonists

    Case report 02 December 2023 Pages: 44 - 44

45. Amiodarone/diltiazem/liothyronine

    Case report 02 December 2023 Pages: 45 - 45

46. Amiodarone/Thiamazole

    Case report 02 December 2023 Pages: 46 - 46

47. Amoxicillin

    Case report 02 December 2023 Pages: 47 - 47

48. Amoxicillin

    Case report 02 December 2023 Pages: 48 - 48

49. Amoxicillin/Clarithromycin/Proton-pump-inhibitors

    Case report 02 December 2023 Pages: 49 - 49

50. Amoxicillin/clavulanic-acid

    Case report 02 December 2023 Pages: 50 - 50